These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8116353)

  • 21. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial.
    Finkelstein JS; Klibanski A; Arnold AL; Toth TL; Hornstein MD; Neer RM
    JAMA; 1998 Sep 23-30; 280(12):1067-73. PubMed ID: 9757854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis.
    Hornstein MD; Hemmings R; Yuzpe AA; Heinrichs WL
    Fertil Steril; 1997 Nov; 68(5):860-4. PubMed ID: 9389816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of nafarelin and leuprolide for endometriosis on quality of life and subjective clinical measures.
    Zhao SZ; Kellerman LA; Francisco CA; Wong JM
    J Reprod Med; 1999 Dec; 44(12):1000-6. PubMed ID: 10649809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain.
    Hornstein MD; Yuzpe AA; Burry KA; Heinrichs LR; Buttram VL; Orwoll ES
    Fertil Steril; 1995 May; 63(5):955-62. PubMed ID: 7720940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of nafarelin in the treatment of endometriosis.
    Henzl MR; Kwei L
    Am J Obstet Gynecol; 1990 Feb; 162(2):570-4. PubMed ID: 2137971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial.
    Parazzini F; Fedele L; Busacca M; Falsetti L; Pellegrini S; Venturini PL; Stella M
    Am J Obstet Gynecol; 1994 Nov; 171(5):1205-7. PubMed ID: 7977520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.
    Burry KA; Patton PE; Illingworth DR
    Am J Obstet Gynecol; 1989 Jun; 160(6):1454-9; discussion 1459-61. PubMed ID: 2525337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nafarelin: a new medical therapy for endometriosis.
    Henzl MR; Monroe SE
    Prog Clin Biol Res; 1990; 323():343-55. PubMed ID: 2137620
    [No Abstract]   [Full Text] [Related]  

  • 29. [The efficacy and safety of nafarelin in treating genital endometriosis].
    Nikolov A; Karag'ozov I; Novachkov V
    Akush Ginekol (Sofiia); 1996; 35(1-2):63-6. PubMed ID: 8967550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nafarelin in the treatment of infertility caused by endometriosis.
    Barlow DH
    Am J Obstet Gynecol; 1990 Feb; 162(2):576-9. PubMed ID: 2137973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan.
    Cheng MH; Yu BK; Chang SP; Wang PH
    J Chin Med Assoc; 2005 Jul; 68(7):307-14. PubMed ID: 16038370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist.
    Hirata JD; Moghissi KS; Ginsburg KA
    Fertil Steril; 1993 Feb; 59(2):444-5. PubMed ID: 8425644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone.
    Eldred JM; Haynes PJ; Thomas EJ
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):354-9. PubMed ID: 1483292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.
    Whitehouse RW; Adams JE; Bancroft K; Vaughan-Williams CA; Elstein M
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):365-73. PubMed ID: 2147597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buserelin versus danazol in the treatment of endometriosis-associated infertility.
    Fedele L; Bianchi S; Arcaini L; Vercellini P; Candiani GB
    Am J Obstet Gynecol; 1989 Oct; 161(4):871-6. PubMed ID: 2529770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
    Taylor HS; Giudice LC; Lessey BA; Abrao MS; Kotarski J; Archer DF; Diamond MP; Surrey E; Johnson NP; Watts NB; Gallagher JC; Simon JA; Carr BR; Dmowski WP; Leyland N; Rowan JP; Duan WR; Ng J; Schwefel B; Thomas JW; Jain RI; Chwalisz K
    N Engl J Med; 2017 Jul; 377(1):28-40. PubMed ID: 28525302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin).
    Monroe SE; Blumenfeld Z; Andreyko JL; Schriock E; Henzl MR; Jaffe RB
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1334-41. PubMed ID: 2946710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
    Finkelstein JS; Klibanski A; Schaefer EH; Hornstein MD; Schiff I; Neer RM
    N Engl J Med; 1994 Dec; 331(24):1618-23. PubMed ID: 7969342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic management of endometriosis.
    Saltiel E; Garabedian-Ruffalo SM
    Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometriosis can evade diagnosis.
    Arbique D; Carter S; Van Sell S
    RN; 2008 Sep; 71(9):28-32; quiz 33. PubMed ID: 18833741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.